A Phase I Clinical Trial of Pazopanib in Combination with Escalating Doses of Radioactive 131I in Patients with Well-Differentiated Thyroid Carcinoma Refractory to Radioiodine, Despite Having Some Uptake.
Phase of Trial: Phase I
Latest Information Update: 01 Sep 2011
At a glance
- Drugs Pazopanib (Primary)
- Indications Thyroid cancer
- Focus Adverse reactions; Therapeutic Use
- 01 Sep 2011 New trial record